Grant Pickering Vaxcyte, Inc. (PCVX) insider trading activity

Grant Pickering is CHIEF EXECUTIVE OFFICER of Vaxcyte, Inc.. Currently has a direct ownership of 465,301 shares of PCVX, which is worth approximately $40 Million. The most recent transaction as insider was on Jan 29, 2024, when has been sold 30,000 shares (Common Stock) at a price of $66.03 per share, resulting in proceeds of $1,980,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 465K

2.84% 3M change

20.57% 12M change

Total Value Held $40 Million

GRANT PICKERING Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2024	SELL Open market or private sale	$1,980,900 $66.03 p/Share	30,000 Reduced 7.39%	375,814 Common Stock
Jan 29 2024	BUY Exercise of conversion of derivative security	$53,700 $1.79 p/Share	30,000 Added 6.88%	405,814 Common Stock
Jan 23 2024	SELL Open market or private sale	$959,700 $63.98 p/Share	15,000 Reduced 3.84%	375,814 Common Stock
Jan 23 2024	BUY Exercise of conversion of derivative security	$13,800 $0.92 p/Share	15,000 Added 3.7%	390,814 Common Stock
Dec 26 2023	SELL Open market or private sale	$925,500 $61.7 p/Share	15,000 Reduced 3.84%	375,814 Common Stock
Dec 26 2023	BUY Exercise of conversion of derivative security	$400 $0.04 p/Share	10,000 Added 2.49%	390,814 Common Stock
Dec 22 2023	BUY Exercise of conversion of derivative security	$20,096 $2.03 p/Share	9,900 Added 2.53%	380,814 Common Stock
Nov 24 2023	SELL Open market or private sale	$738,150 $49.21 p/Share	15,000 Reduced 3.89%	370,914 Common Stock
Oct 23 2023	SELL Open market or private sale	$707,400 $47.16 p/Share	15,000 Reduced 3.74%	385,914 Common Stock
Sep 25 2023	SELL Open market or private sale	$786,750 $52.45 p/Share	15,000 Reduced 3.61%	400,914 Common Stock
Sep 05 2023	SELL Payment of exercise price or tax liability	$529,278 $51.0 p/Share	10,378 Reduced 2.43%	415,914 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$128,577 $41.49 p/Share	3,099 Reduced 0.72%	425,252 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	53,875 Added 11.17%	428,351 Common Stock
Dec 30 2022	BUY Exercise of conversion of derivative security	$30,770 $2.03 p/Share	15,158 Added 3.89%	374,476 Common Stock
Sep 15 2022	SELL Open market or private sale	$307,450 $27.95 p/Share	11,000 Reduced 1.66%	652,546 Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$235,046 $26.38 p/Share	8,910 Reduced 1.32%	663,546 Common Stock
Aug 15 2022	SELL Open market or private sale	$285,120 $25.92 p/Share	11,000 Reduced 1.61%	672,456 Common Stock
Jul 15 2022	SELL Open market or private sale	$270,710 $24.61 p/Share	11,000 Reduced 1.58%	683,456 Common Stock
Jun 24 2022	SELL Open market or private sale	$15,694 $21.01 p/Share	747 Reduced 0.11%	694,456 Common Stock
Jun 23 2022	SELL Open market or private sale	$74,396 $21.01 p/Share	3,541 Reduced 0.51%	695,203 Common Stock
Jun 22 2022	SELL Open market or private sale	$26,494 $21.01 p/Share	1,261 Reduced 0.18%	698,744 Common Stock
Jun 21 2022	SELL Open market or private sale	$114,744 $21.05 p/Share	5,451 Reduced 0.77%	700,005 Common Stock
May 16 2022	SELL Open market or private sale	$264,220 $24.02 p/Share	11,000 Reduced 1.54%	703,894 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	$19,690 $1.79 p/Share	11,000 Added 1.52%	714,894 Common Stock
Apr 18 2022	SELL Open market or private sale	$263,780 $23.98 p/Share	11,000 Reduced 1.54%	703,894 Common Stock

Also insider at

ATHA

Athira Pharma, Inc. Healthcare

Grant Pickering

CHIEF EXECUTIVE OFFICER

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account